ARK Genomic Revolution ETF vs Booz Allen Hamilton Holding Corporation — how do they compare? ARK Genomic Revolution ETF trades at $44.5, while Booz Allen Hamilton Holding Corporation trades at $78.36 (market cap $9.45B). The key difference: Booz Allen Hamilton Holding Corporation pays a 3% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Booz Allen Hamilton Holding Corporation nearer its low. Which is the better fit depends on your goals.
| ARKG | BAH | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $44.55 | $111.63 |
52-Week Low | $24.02 | $59.71 |
Market Cap | — | $9.45B |
Enterprise Value | — | $13.07B |
Dividend Yield | — | 3% |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.
Read more on BAH →